JP Morgan Maintains Overweight on CytomX Therapeutics, Lowers Price Target to $11
JP Morgan analyst Anupam Rama maintains CytomX Therapeutics (NASDAQ:CTMX) with a Overweight and lowers the price target from $12 to $11.
Benzinga22 gün önceCTMX
CytomX Therapeutics: Promising Varseta-M With Comfortable Runway
CTMX stock outlook: PROBODY platform, Varseta-M colorectal cancer data, and catalysts through 1H2027 plus expanded Regeneron deal. Click here to read.
SeekingAlpha23 gün önceCTMX
Guggenheim Maintains Buy on CytomX Therapeutics, Lowers Price Target to $14
Guggenheim analyst Michael Schmidt maintains CytomX Therapeutics (NASDAQ:CTMX) with a Buy and lowers the price target from $15 to $14.
Benzinga25 gün önceCTMX
CytomX Therapeutics Inc (CTMX) (Q2 2026) Earnings Call Highlights: Varetta M Advances Toward ...
Strong clinical progress and expanded Regeneron collaboration bolster CytomX's path forward despite revenue decline and safety considerations.
Yahoo28 gün önceCTMX
CytomX Therapeutics Q2 Earnings Call Highlights
CytomX Therapeutics (NASDAQ:CTMX) said its second-quarter focus remained on advancing Varseta-M, an EpCAM-targeting antibody-drug conjugate being developed for metastatic colorectal cancer, while expanding the program into combination regimens and additional gastrointestinal cancers. Chief Executiv
Yahoo28 gün önceCTMX
CytomX Therapeutics (NASDAQ:CTMX) Shares Plunge After Q2 Revenue and EPS Miss Estimates
Cytomx (CTMX) shares fell ~30% after Q2 revenue and EPS missed estimates. Lead program Varseta-M Phase 1 data expected by end of 2026.
ChartMill28 gün önceCTMX
CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of +18.18% and -80.21%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo28 gün önceCTMX
CytomX Therapeutics, Inc. (CTMX) Q2 2026 Earnings Call Transcript
CytomX Therapeutics, Inc. (CTMX) Q2 2026 Earnings Call August 6, 2026 5:00 PM EDTCompany ParticipantsChris Ogden - SVP, CFO & SecretarySean McCarthy -...
SeekingAlpha28 gün önceCTMX